Acyclovir / valacyclovir (oral)
Orals / systemic · Rx
RxOrals / systemicAntiviralPreservative-free option
| Strength | Acyclovir 400 mg; valacyclovir 500 mg-1 g |
|---|---|
| Drug class | Antiviral, systemic (adjunct to eye care) |
| Mechanism of action | Guanosine analogs activated by viral thymidine kinase; inhibit viral DNA polymerase. Oral route achieves therapeutic corneal/anterior-chamber levels. |
| Indication / reason for use | HSV epithelial and stromal keratitis, herpetic iritis; herpes zoster ophthalmicus; long-term prophylaxis of recurrent HSV keratitis (HEDS regimen). |
| Usual adult dosing | HSV keratitis: aciclovir 400 mg 5×/day (or valaciclovir 500 mg TID) for 7-10 days. HZO: aciclovir 800 mg 5×/day or valaciclovir 1 g TID for 7-10 days, started within 72 h. Prophylaxis: aciclovir 400 mg BID. |
| Preservative | N/A (oral) , a preservative-free option exists |
| Contact lenses | No ocular product; lens restrictions relate to the keratitis itself. |
| Common / important adverse effects | Nausea, headache; renal impairment with dehydration (ensure fluids); rare TTP/HUS with high-dose valaciclovir in immunocompromised. |
| Contraindications & cautions | Dose-adjust in renal impairment. |
| Pregnancy / lactation | Aciclovir has extensive reassuring pregnancy data; preferred when systemic antiviral is needed. |
| Trade names | Zovirax (oral), Valtrex |
| Practice notes | HEDS trial: 400 mg BID roughly halves the recurrence rate of HSV epithelial and stromal keratitis over 12 months. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.